Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TIL Instil Bio, Inc.

未开盘 05-16 16:00:00 EDT

11.80

-0.30

-2.48%

盘后11.80

+0.000.00%

16:06 EDT

最高12.00	最低11.61	成交量6,595
今开12.00	昨收12.10	日振幅3.22%
总市值7,675万	流通市值3,606万	总股本650.39万
成交额7.85万	换手率0.22%	流通股本305.56万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TIL","market":"US","secType":"STK","nameCN":"Instil Bio, Inc.","latestPrice":11.8,"timestamp":1715889600000,"preClose":12.1,"halted":0,"volume":6595,"hourTrading":{"tag":"盘后","latestPrice":11.8,"preClose":11.8,"latestTime":"16:06 EDT","volume":1,"amount":11.57,"timestamp":1715890010958},"delay":0,"floatShares":3055598,"shares":6503913,"eps":-18.961046,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.3,"latestTime":"05-16 16:00:00 EDT","open":12,"high":12,"low":11.61,"amount":78458.109975,"amplitude":0.032231,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-18.961046,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715932800000},"adr":0,"listingDate":1616126400000,"adjPreClose":12.1,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":12.1,"preClose":12,"latestTime":"09:26 EDT","volume":100,"amount":1210,"timestamp":1715865990021},"postHourTrading":{"tag":"盘后","latestPrice":11.8,"preClose":11.8,"latestTime":"16:06 EDT","volume":1,"amount":11.57,"timestamp":1715890010958},"volumeRatio":0.295372},"requestUrl":"/m/hq/s/TIL","defaultTab":"news","newsList":[{"id":"2434857616","title":"Instil Bio Inc 公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434857616","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2434857616?lang=zh_cn&edition=full","pubTime":"2024-05-10 22:26","pubTimestamp":1715351190,"startTime":"0","endTime":"0","summary":"   * Instil Bio Inc   报告了截至3月底的季度调整后每股亏损3.74美元，高于去年同期的每股收益8.80美元。两位分析师对该季度的平均预期是每股亏损 2.23 美元。华尔街预期为每股亏损 2.30 美元至 2.16 美元。* Instil Bio Inc 公布的季度每股收益为亏损 3.74 美元。* 该公司当季亏损2430万美元。* Instil Bio Inc 本季度股价上涨了 4.0%，今年迄今为止上涨了 47.4%。5月10日 - 预测变化   * 在过去三个月里，分析师的平均盈利预测上升了约 25.5%。华尔街对 Instil Bio Inc 的 12 个月目标价中位数为 18.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2434805854","title":"Instil Bio, Inc.盘中异动 早盘快速上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434805854","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434805854?lang=zh_cn&edition=full","pubTime":"2024-05-10 21:33","pubTimestamp":1715348016,"startTime":"0","endTime":"0","summary":"北京时间2024年05月10日21时33分，Instil Bio, Inc.股票出现波动，股价急速拉升5.16%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102133377a5940b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405102133377a5940b7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433302788","title":"Instil Bio, Inc.盘中异动 早盘快速下挫5.29%报10.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433302788","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433302788?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:48","pubTimestamp":1715089694,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时48分，Instil Bio, Inc.股票出现异动，股价急速跳水5.29%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Clearmind Medicine Inc.、Geovax Labs Inc C/Wts 29/09/2025、珐博进涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为1153.46%、134.16%、47.06%，振幅较大的相关个股有Tc Biopharm  Plc、Corvus Pharmaceuticals, Inc.、Clearmind Medicine Inc.，振幅分别为31.03%、26.70%、23.93%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发自体肿瘤浸润淋巴细胞的细胞治疗管道，以治疗癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072148157a5885da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072148157a5885da&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433720641","title":"Instil Bio Inc   预计每股亏损2.23美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433720641","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433720641?lang=zh_cn&edition=full","pubTime":"2024-05-07 20:34","pubTimestamp":1715085279,"startTime":"0","endTime":"0","summary":"   * Instil Bio Inc    预计在5月9日公布截至0001年1月1日的业绩(估计)，季度收入将没有变化。*    * LSEG 的分析师平均预计 Instil Bio Inc 每股亏损 2.23 美元。* 华尔街对 Instil Bio Inc 的 12 个月目标价中位数为 18.00 美元，高于其最新收盘价 11.54 美元。5月7日 - 本摘要于北京时间 5 月 7 日 12:34 机器生成。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431837539","title":"在外部环境挑战下，药明康德2024年第一季度达成目标，保持稳健经营","url":"https://stock-news.laohu8.com/highlight/detail?id=2431837539","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2431837539?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:02","pubTimestamp":1714388520,"startTime":"0","endTime":"0","summary":"2024年第一季度，公司新增客户超过300家，过去12个月服务的活跃客户超过6,000家，全球各地客户对公司服务的需求持续增长。化学业务D&M分子管线保持快速增长，报告期内累计新增分子337个；截至2024年第一季度末，D&M分子管线总数总计3,286个，其中商业化和临床III期项目在报告期内合计新增11个。管理层评论 药明康德董事长兼首席执行官李革博士表示：\"2024年第一季度，公司如期达成设定目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4399640_ZH99640_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426762202","title":"美国研究综述-Cheesecake Factory、Netflix、Texas Roadhouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2426762202","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2426762202?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:04","pubTimestamp":1712905476,"startTime":"0","endTime":"0","summary":"    路透社4月12日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Cheesecake Factory、Netflix 和 Texas Roadhouse。要闻             * Cheesecake Factory Inc   ：斯蒂芬斯恢复覆盖，给予增持评级             * Netflix Inc   ：Piper Sandler将目标价从550美元上调至600美元             * Texas Roadhouse Inc   ：斯蒂芬斯恢复对该公司的研究，给予等权重评级 以下是路透社周五报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2421181264","title":"Instil Bio, Inc.盘中异动 早盘股价大跌6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421181264","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421181264?lang=zh_cn&edition=full","pubTime":"2024-03-22 22:08","pubTimestamp":1711116508,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日22时08分，Instil Bio, Inc.股票出现异动，股价大幅下挫6.12%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发一种创新的细胞治疗管道，自体肿瘤浸润淋巴细胞，或TIL，治疗癌症患者的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322220828791c4f97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322220828791c4f97&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419638318","title":"Instil Bio, Inc.盘中异动 急速拉升6.64%报12.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419638318","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419638318?lang=zh_cn&edition=full","pubTime":"2024-03-13 22:23","pubTimestamp":1710339822,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日22时23分，Instil Bio, Inc.股票出现异动，股价快速上涨6.64%。Instil Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发一种创新的细胞治疗管道，自体肿瘤浸润淋巴细胞，或TIL，治疗癌症患者的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313222343861dde0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240313222343861dde0e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419564462","title":"Instil Bio, Inc.盘中异动 快速拉升5.64%报12.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419564462","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419564462?lang=zh_cn&edition=full","pubTime":"2024-03-13 03:01","pubTimestamp":1710270066,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日03时01分，Instil Bio, Inc.股票出现波动，股价大幅拉升5.64%。截至发稿，该股报12.36美元/股，成交量2.6356万股，换手率0.41%，振幅6.50%。Instil Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.17%。Instil Bio, Inc.公司简介：Instil Bio Inc 是一家临床阶段的生物制药公司，专注于开发一种创新的细胞治疗管道，自体肿瘤浸润淋巴细胞，或TIL，治疗癌症患者的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403130301067919c7e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403130301067919c7e2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413141442","title":"Iovance Biotherapeutics Inc盘中异动 股价大涨5.01%报16.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413141442","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413141442?lang=zh_cn&edition=full","pubTime":"2024-02-22 22:40","pubTimestamp":1708612825,"startTime":"0","endTime":"0","summary":"北京时间2024年02月22日22时40分，Iovance Biotherapeutics Inc股票出现波动，股价快速拉升5.01%。截至发稿，该股报16.56美元/股，成交量418.464万股，换手率1.64%，振幅7.86%。Iovance Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为1.01%。Iovance Biotherapeutics Inc公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022222402579138262&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022222402579138262&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413023149","title":"细胞基因治疗大变革？美国尝试高价药物新付费模式 | 见智研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2413023149","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2413023149?lang=zh_cn&edition=full","pubTime":"2024-02-22 11:21","pubTimestamp":1708572062,"startTime":"0","endTime":"0","summary":"可能改变细胞基因治疗当下的付费窘境。","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/7c68a368-f423-4bc4-94bc-cd41621ce3bf.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/7c68a368-f423-4bc4-94bc-cd41621ce3bf.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3708783","is_publish_highlight":false,"gpt_icon":0},{"id":"2413236558","title":"港股异动 | 科济药业-B(02171)涨超10% 全球首款TIL疗法获批上市 机构建议关注细胞治疗赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2413236558","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2413236558?lang=zh_cn&edition=full","pubTime":"2024-02-22 10:24","pubTimestamp":1708568640,"startTime":"0","endTime":"0","summary":"科济药业-B涨超10%，截至发稿，涨10.48%，报6.22港元，成交额491.23万港元。民生证券表示，细胞治疗领域进展不断，建议关注细胞治疗公司和相关产业链，包括科济药业等。据悉，从研发管线来看，科济药业的主要候选产品泽沃基奥仑赛注射液，是一种用于治疗复发/难治多发性骨髓瘤的自体BCMA CAR-T细胞候选产品，在管线中最接近商业化。此外，科济药业的实体瘤候选产品CT041处于确证性II期临床试验、CT011处于I期临床试验，AB011处于Ib期临床试验阶段。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-02-22/doc-inaiwnsk9567252.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-02-22/doc-inaiwnsk9567252.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2413782426","title":"Iovance Biotherapeutics Inc盘中异动 早盘急速拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413782426","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413782426?lang=zh_cn&edition=full","pubTime":"2024-02-21 22:33","pubTimestamp":1708526014,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日22时33分，Iovance Biotherapeutics Inc股票出现异动，股价大幅上涨5.22%。Iovance Biotherapeutics Inc股票所在的生物技术行业中，整体跌幅为0.08%。Iovance Biotherapeutics Inc公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402212233347a455e49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402212233347a455e49&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412039361","title":"Iovance Biotherapeutics Inc盘中异动 股价大涨31.04%报11.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2412039361","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412039361?lang=zh_cn&edition=full","pubTime":"2024-02-20 22:32","pubTimestamp":1708439536,"startTime":"0","endTime":"0","summary":"北京时间2024年02月20日22时32分，Iovance Biotherapeutics Inc股票出现波动，股价快速拉升31.04%。截至发稿，该股报11.99美元/股，成交量914.559万股，换手率3.57%，振幅8.52%。Iovance Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为0.36%。Iovance Biotherapeutics Inc公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022321681a00d6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022022321681a00d6a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412613598","title":"Iovance Biotherapeutics Inc盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412613598","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2412613598?lang=zh_cn&edition=full","pubTime":"2024-02-17 04:49","pubTimestamp":1708116569,"startTime":"0","endTime":"0","summary":"北京时间2024年02月17日04时49分，Iovance Biotherapeutics Inc股票出现异动，股价急速下跌5.03%。Iovance Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为0.01%。Iovance Biotherapeutics Inc公司简介：Iovance Biotherapeutics Inc 是一家临床阶段的生物制药公司，通过利用人体免疫系统识别和破坏多种癌细胞的能力，采用针对每位患者的个性化疗法，开创了治疗癌症的变革性方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402170449297a440b2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402170449297a440b2d&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"https://instilbio.com/","stockEarnings":[{"period":"1week","weight":0.0508},{"period":"1month","weight":0.1423},{"period":"3month","weight":0.0034},{"period":"6month","weight":0.6389},{"period":"1year","weight":-0.0186},{"period":"ytd","weight":0.5486}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Instil Bio, Inc.总部位于德克萨斯州达拉斯，于2018年8月在特拉华州注册成立。该公司是一家临床阶段生物制药公司，致力于开发创新的自体肿瘤浸润淋巴细胞（TIL）治疗细胞疗法，以治疗癌症患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.173004},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.036947},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.080585},{"month":4,"riseRate":0.25,"avgChangeRate":-0.133235},{"month":5,"riseRate":0.25,"avgChangeRate":-0.068765},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.075587},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.003103},{"month":8,"riseRate":0.333333,"avgChangeRate":0.000223},{"month":9,"riseRate":0,"avgChangeRate":-0.057388},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.103927},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.201575},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.207775}],"exchange":"NASDAQ","name":"Instil Bio, Inc.","nameEN":"Instil Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Instil Bio, Inc.,TIL,Instil Bio, Inc.股票,Instil Bio, Inc.股票老虎,Instil Bio, Inc.股票老虎国际,Instil Bio, Inc.行情,Instil Bio, Inc.股票行情,Instil Bio, Inc.股价,Instil Bio, Inc.股市,Instil Bio, Inc.股票价格,Instil Bio, Inc.股票交易,Instil Bio, Inc.股票购买,Instil Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Instil Bio, Inc.(TIL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Instil Bio, Inc.(TIL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况